{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:53:13Z","timestamp":1789854793677,"version":"4.0.1"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:named-content content-type=\"genus-species\">Neisseria<\/jats:named-content>adhesin A (NadA), involved in the adhesion and invasion of<jats:named-content content-type=\"genus-species\">Neisseria meningitidis<\/jats:named-content>into host tissues, is one of the major components of Bexsero, a novel multicomponent vaccine licensed for protection against meningococcal serogroup B in Europe, Australia, and Canada. NadA has been identified in approximately 30% of clinical isolates and in a much lower proportion of carrier isolates. Three protein variants were originally identified in invasive meningococci and named NadA-1, NadA-2, and NadA-3, whereas most carrier isolates either lacked the gene or harbored a different variant, NadA-4. Further analysis of isolates belonging to the sequence type 213 (ST-213) clonal complex identified NadA-5, which was structurally similar to NadA-4, but more distantly related to NadA-1, -2, and -3. At the time of this writing, more than 89 distinct<jats:italic>nadA<\/jats:italic>allele sequences and 43 distinct peptides have been described. Here, we present a revised nomenclature system, taking into account the complete data set, which is compatible with previous classification schemes and is expandable. The main features of this new scheme include (i) the grouping of the previously named NadA-2 and NadA-3 variants into a single NadA-2\/3 variant, (ii) the grouping of the previously assigned NadA-4 and NadA-5 variants into a single NadA-4\/5 variant, (iii) the introduction of an additional variant (NadA-6), and (iv) the classification of the variants into two main groups, named groups I and II. To facilitate querying of the sequences and submission of new allele sequences, the nucleotide and amino acid sequences are available at<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/pubmlst.org\/neisseria\/NadA\/\">http:\/\/pubmlst.org\/neisseria\/NadA\/<\/jats:ext-link>.<\/jats:p>","DOI":"10.1128\/cvi.00825-13","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:28:50Z","timestamp":1399508930000},"page":"966-971","source":"Crossref","is-referenced-by-count":58,"title":["Neisseria Adhesin A Variation and Revised Nomenclature Scheme"],"prefix":"10.1128","volume":"21","author":[{"given":"Stefania","family":"Bambini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"De Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Muzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marirosa","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lucidarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Brehony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vega","family":"Masignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Comanducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C. J.","family":"Maiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Jolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2014,5,7]]},"reference":[{"key":"key20180919073737_B1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","article-title":"Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells","volume":"55","author":"Capecchi","year":"2005","journal-title":"Mol. Microbiol."},{"key":"key20180919073737_B2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1189\/jlb.1207810","article-title":"Human monocytes\/macrophages are a target of Neisseria meningitidis adhesin A (NadA)","volume":"83","author":"Franzoso","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"key20180919073737_B3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1189\/jlb.0109030","article-title":"The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA-OMVs, without further stimulating their proinflammatory activity on circulating monocytes","volume":"86","author":"Tavano","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"key20180919073737_B4","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.4049\/jimmunol.179.6.3904","article-title":"IFN-gamma and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A","volume":"179","author":"Mazzon","year":"2007","journal-title":"J. Immunol."},{"key":"key20180919073737_B5","doi-asserted-by":"publisher","first-page":"e25089","DOI":"10.1371\/journal.pone.0025089","article-title":"The soluble recombinant Neisseria meningitidis adhesin NadA(\u0394351-405) stimulates human monocytes by binding to extracellular Hsp90","volume":"6","author":"Cecchini","year":"2011","journal-title":"PLoS One"},{"key":"key20180919073737_B6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1462-5822.2011.01722.x","article-title":"Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin A (NadA)-mediated adhesion and invasion","volume":"14","author":"Montanari","year":"2012","journal-title":"Cell. Microbiol."},{"key":"key20180919073737_B7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/MMBR.62.4.1315-1352.1998","article-title":"The virulence plasmid of Yersinia, an antihost genome","volume":"62","author":"Cornelis","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"key20180919073737_B8","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/IAI.67.3.1310-1316.1999","article-title":"The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children","volume":"67","author":"Chen","year":"1999","journal-title":"Infect. Immun."},{"key":"key20180919073737_B9","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1128\/JB.185.13.3735-3744.2003","article-title":"Molecular analysis of transport and oligomerization of the Yersinia enterocolitica adhesin YadA","volume":"185","author":"Roggenkamp","year":"2003","journal-title":"J. Bacteriol."},{"key":"key20180919073737_B10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J. Exp. Med."},{"key":"key20180919073737_B11","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1086\/424464","article-title":"Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease","volume":"190","author":"Litt","year":"2004","journal-title":"J. Infect. Dis."},{"key":"key20180919073737_B12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1365-2958.2003.03678.x","article-title":"Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation","volume":"50","author":"Martin","year":"2003","journal-title":"Mol. Microbiol."},{"key":"key20180919073737_B13","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1073\/pnas.0406805102","article-title":"Microsatellite instability regulates transcription factor binding and gene expression","volume":"102","author":"Martin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073737_B14","doi-asserted-by":"publisher","first-page":"e1000710","DOI":"10.1371\/journal.ppat.1000710","article-title":"A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements","volume":"5","author":"Metruccio","year":"2009","journal-title":"PLoS Pathog."},{"key":"key20180919073737_B15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1128\/IAI.01085-12","article-title":"Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine","volume":"81","author":"Fagnocchi","year":"2013","journal-title":"Infect. Immun."},{"key":"key20180919073737_B16","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/JB.06161-11","article-title":"In the NadR regulon, adhesins and diverse meningococcal functions are regulated in response to signals in human saliva","volume":"194","author":"Fagnocchi","year":"2012","journal-title":"J. Bacteriol."},{"key":"key20180919073737_B17","doi-asserted-by":"publisher","first-page":"e56097","DOI":"10.1371\/journal.pone.0056097","article-title":"MtrR control of a transcriptional regulatory pathway in Neisseria meningitidis that influences expression of a gene (nadA) encoding a vaccine candidate","volume":"8","author":"Cloward","year":"2013","journal-title":"PLoS One"},{"key":"key20180919073737_B18","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1128\/JCM.00936-09","article-title":"Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales","volume":"47","author":"Lucidarme","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073737_B19","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infect. Immun."},{"key":"key20180919073737_B20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.vaccine.2008.12.052","article-title":"Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease","volume":"27","author":"Jacobsson","year":"2009","journal-title":"Vaccine"},{"key":"key20180919073737_B21","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","article-title":"Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus","volume":"27","author":"Bambini","year":"2009","journal-title":"Vaccine"},{"key":"key20180919073737_B22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3201\/eid1801.110901","article-title":"Invasive meningococcal capsular group Y disease, England and Wales, 2007\u20132009","volume":"18","author":"Ladhani","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"key20180919073737_B23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1128\/CVI.00027-10","article-title":"Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine","volume":"17","author":"Lucidarme","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073737_B24","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"key20180919073737_B25","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073737_B26","doi-asserted-by":"publisher","first-page":"e65043","DOI":"10.1371\/journal.pone.0065043","article-title":"An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands","volume":"8","author":"Bambini","year":"2013","journal-title":"PLoS One"},{"key":"key20180919073737_B27","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp. Ser."},{"key":"key20180919073737_B28","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0","volume":"24","author":"Tamura","year":"2007","journal-title":"Molecular biology and evolution."},{"key":"key20180919073737_B29","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2\u2014a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"key20180919073737_B30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/molbev\/msj030","article-title":"Application of phylogenetic networks in evolutionary studies","volume":"23","author":"Huson","year":"2006","journal-title":"Mol. Biol. Evol."},{"key":"key20180919073737_B31","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/S0140-6736(00)03502-9","article-title":"Serogroup W135 meningococcal disease in Hajj pilgrims","volume":"356","author":"Taha","year":"2000","journal-title":"Lancet"},{"key":"key20180919073737_B32","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1086\/340414","article-title":"Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex","volume":"185","author":"Mayer","year":"2002","journal-title":"J. Infect. Dis."},{"key":"key20180919073737_B33","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1128\/JCM.42.9.4158-4163.2004","article-title":"Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000","volume":"42","author":"Taha","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073737_B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"key20180919073737_B35","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1128\/IAI.01358-12","article-title":"Phase variation of PorA, a major outer membrane protein, mediates escape of bactericidal antibodies by Neisseria meningitidis","volume":"81","author":"Tauseef","year":"2013","journal-title":"Infect. Immun."},{"key":"key20180919073737_B36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/JCM.01495-08","article-title":"B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain","volume":"47","author":"Castilla","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073737_B37","doi-asserted-by":"publisher","first-page":"e00163","DOI":"10.1128\/mBio.00163-13","article-title":"Conservation of meningococcal antigens in the genus Neisseria","volume":"4","author":"Muzzi","year":"2013","journal-title":"mBio"},{"key":"key20180919073737_B38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin. Infect. Dis."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00825-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:50:59Z","timestamp":1627591859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00825-13"}},"subtitle":[],"editor":[{"given":"D. L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,7]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,6,30]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1128\/CVI.00825-13"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00825-13","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,7]]}}}